Correction to: Nature Nanotechnology https://doi.org/10.1038/s41565-021-00898-0, published online 31 May 2021.
In Table 2 of the version of this Review originally published, the nucleic acid therapeutic ‘Nedosiran’ was incorrectly listed as a GalNAc–ASO conjugate, but it is a GalNAc–siRNA conjugate. Table 2 has now been amended accordingly in the online versions of the Review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kulkarni, J.A., Witzigmann, D., Thomson, S.B. et al. Author Correction: The current landscape of nucleic acid therapeutics. Nat. Nanotechnol. 16, 841 (2021). https://doi.org/10.1038/s41565-021-00937-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-021-00937-w
This article is cited by
-
The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges
Stem Cell Research & Therapy (2023)